Capmatinib and Savotinib prices

Capmatinib is a targeted therapy drug mainly used to treat non-small cell lung cancer (NSCLC). This type of cancer is usually related to the abnormal expression or activation of MET (tyrosine kinase) protein. The mechanism of action of capmatinib is to inhibit the activity of MET kinase and block abnormal growth signaling, thereby inhibiting the development of lung cancer.

Capmatinib is usually used in patients with METgene mutations or METoverexpressionNSCLC, which allows the drug to act more specifically on specific molecular abnormalities and improve therapeutic effects. In clinical application, capmatinib may be used as a first-line treatment option and can also be used for patients who are ineffective or intolerant to traditional treatments (such as radiotherapy and chemotherapy).

The specific dosage and usage of this drug are usually based on the patient's physical condition, illness, and doctor's prescription. Capmatinib is usually taken as an oral medication and its side effects are relatively mild, but patients still need close monitoring and regular follow-up during use.

Savolitinib (Savolitinib) is an oral small molecule targeted therapy drug. It is mainly used to treat a specific type of molecular abnormality in renal cell carcinoma, namely the abnormal activation of the MET (tyrosine kinase) pathway.

Savotinib inhibits tumor growth and spread by selectively inhibiting the activity ofMETkinase and blocking abnormal cell signaling. This treatment is particularly suitable for patients with renal cell carcinoma who have overexpression or genetic mutations of MET kinase, providing a more targeted treatment option for this specific subpopulation.

Capmatinib is not yet available in China, so patients cannot purchase it domestically yet and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same. Savotinib is a domestic drug with a price of more than 5,000 yuan.